Company Filing History:
Years Active: 2025
Title: The Innovations of Nicholas Raffaele
Introduction
Nicholas Raffaele is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. His work has led to the creation of a patent that showcases his innovative approach to drug design.
Latest Patents
Nicholas Raffaele holds a patent for crystalline forms of a MAGL inhibitor. The patent, titled "Crystalline forms of the MAGL inhibitor 1,1,1,3,3,3-Hexafluoropropan-2-yl(S)-1-(pyridazin-3-ylcarbamoyl)-6-azaspiro[2.5]octane-6-carboxylate," highlights his expertise in creating effective pharmaceutical agents. This invention represents a significant advancement in the treatment of various medical conditions.
Career Highlights
Raffaele's career is marked by his dedication to research and development in the pharmaceutical industry. He is currently employed at H. Lundbeck A/S, a global pharmaceutical company known for its focus on brain diseases. His role at Lundbeck allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Nicholas has worked alongside notable colleagues, including Thomas Vetter and John J. M. Wiener. These collaborations have fostered an environment of innovation and have led to the successful development of new therapeutic solutions.
Conclusion
Nicholas Raffaele is a prominent figure in the pharmaceutical industry, known for his innovative contributions and successful patent. His work continues to impact the field positively, paving the way for future advancements in drug development.